Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
Brentuximab vedotin治疗复发或难治性霍奇金淋巴瘤:土耳其的经验
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-014-2215-9
Salihoglu, A; Elverdi, T; Karadogan, I; Paydas, S; Ozdemir, E; Erdem, G; Karadurmus, N; Akyol, G; Kaynar, L; Yegin, Za; Sucak, G; Ozkocaman, V; Topcuoglu, P; Ozcan, M; Birtas, E; Goker, H; Baslar, Z; Ferhanoglu, B